CEO Ray Hill discusses real-world data (RWD) and real-world evidence (RWE) in the evolving product approval landscape.
- Learn why regulators prioritize RWD and how regulatory agencies utilize this data.
- Explore the benefits of syndicated registries for bespoke and longitudinal studies.
- Gain insights on how to navigate the abundance of available data and analyzing the right dataset.
